[HTML][HTML] Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

JY Sun, D Zhang, S Wu, M Xu, X Zhou, XJ Lu, J Ji - Biomarker Research, 2020 - Springer
Abstract PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has
revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 …

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives.

JY Sun, D Zhang, S Wu, M Xu, X Zhou, XJ Lu… - Biomarker …, 2020 - europepmc.org
Abstract PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has
revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 …

[HTML][HTML] Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

JY Sun, D Zhang, S Wu, M Xu… - Biomarker …, 2020 - biomarkerres.biomedcentral.com
PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has
revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 …

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives.

JY Sun, D Zhang, S Wu, M Xu, X Zhou… - Biomarker …, 2020 - search.ebscohost.com
Abstract PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has
revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 …

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

JY Sun, D Zhang, S Wu, M Xu, X Zhou… - Biomarker …, 2020 - pubmed.ncbi.nlm.nih.gov
PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has
revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 …

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

S Jin-Yu, D Zhang, S Wu, M Xu, X Zhou… - Biomarker …, 2020 - search.proquest.com
Abstract PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has
revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 …

[引用][C] Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

JY Sun, D Zhang, S Wu, M Xu, X Zhou… - Biomarker Research …, 2020 - jglobal.jst.go.jp
Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors,
and future perspectives | Article Information | J-GLOBAL Art J-GLOBAL ID:202102272371825386 …

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives.

JY Sun, D Zhang, S Wu, M Xu, X Zhou, XJ Lu… - Biomarker …, 2020 - go.gale.com
PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has
revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 …

[HTML][HTML] Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

JY Sun, D Zhang, S Wu, M Xu, X Zhou, XJ Lu… - Biomarker …, 2020 - ncbi.nlm.nih.gov
Abstract PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has
revolutionized the treatment landscape of malignancies. Over the last decade, PD-1/PD-L1 …

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives

JY Sun, D Zhang, S Wu, M Xu, X Zhou, XJ Lu, J Ji - Biomarker Research, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> PD-1/PD-L1 blockade therapy is a promising
cancer treatment strategy, which has revolutionized the treatment landscape of …